Clinical trial
Patients Preference for Oral or i.v. Therapy
NCT00212589 · Odense University Hospital, Other · Completed
Key facts
| NCT number | NCT00212589 |
|---|---|
| Title | Patients Preference for Oral or i.v. Therapy |
| Official title | A Randomized Crossover Trial Comparing Oral Capecitabine and Intravenous Fluorouracil + Folinic Acid (Nordic FU/FA Regimen) for Patient Preference in Colorectal Cancer |
| Lead sponsor | Odense University Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine, Fluorouracil + folinic acid |
| Enrollment | 60 |
| Start date | Dec 1, 2002 |
| Completion | Apr 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 21, 2005 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: